Long-term effectiveness of add-on stiripentol: an observational study in Dravet syndrome and non-Dravet developmental and epileptic encephalopathies

被引：0
|
作者：
Aledo-Serrano, Angel [1 ]
Gil-Nagel, Antonio [1 ]
Martinez-Vicente, Laura [1 ]
Jimenez-Huete, Adolfo [1 ]
Toledano, Rafael [1 ]
Garcia Morales, Irene [1 ]
机构：
[1] Hosp Ruber Internacl, Neurol, Madrid, Spain
来源：
EPILEPSIA | 2021年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1164
引用
收藏
页码：167 / 167
页数：1
相关论文
共 50 条
  • [1] Efficacy and tolerability of add-on stiripentol in real-world clinical practice: An observational study in Dravet syndrome and non-Dravet developmental and epileptic encephalopathies
    Gil-Nagel, Antonio
    Aledo-Serrano, Angel
    Beltran-Corbellini, Alvaro
    Martinez-Vicente, Laura
    Jimenez-Huete, Adolfo
    Toledano-Delgado, Rafael
    Gacia-Morales, Irene
    Valls-Carbo, Adrian
    [J]. EPILEPSIA OPEN, 2024, 9 (01) : 164 - 175
  • [2] Long-term pragmatic use of stiripentol for Dravet syndrome
    Chiron, Catherine
    [J]. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2018, 60 (06): : 535 - 535
  • [3] Effectiveness of add-on stiripentol to clobazam and valproate in Japanese patients with Dravet syndrome: Additional supportive evidence
    Inoue, Yushi
    Ohtsuka, Yoko
    [J]. EPILEPSY RESEARCH, 2014, 108 (04) : 725 - 731
  • [4] Low long-term efficacy and tolerability of add-on rufinamide in patients with Dravet syndrome
    Mueller, A.
    Boor, R.
    Coppola, G.
    Striano, P.
    Dahlin, M.
    von Stuelpnagel, C.
    Lotte, J.
    Staudt, M.
    Kluger, G.
    [J]. EPILEPSY & BEHAVIOR, 2011, 21 (03) : 282 - 284
  • [5] Long-Term Use of Stiripentol (Diacomit®) from Childhood to Adulthood in Patients with Dravet Syndrome
    Chiron, C.
    Helias, M.
    Kaminska, A.
    Nabbout, R.
    de Toffol, B.
    Laroche, C.
    An, I.
    [J]. EPILEPSIA, 2018, 59 : S109 - S109
  • [6] Long-term safety and effectiveness of stiripentol in patients with Dravet syndrome: Interim report of a post-marketing surveillance study in Japan
    Yamada, Miyuki
    Suzuki, Katsuyoshi
    Matsui, Daisuke
    Inoue, Yushi
    Ohtsuka, Yoko
    [J]. EPILEPSY RESEARCH, 2021, 170
  • [7] Add-on cannabidiol in patients with Dravet syndrome: Results of a long-term open-label extension trial
    Scheffer, Ingrid E.
    Halford, Jonathan J.
    Miller, Ian
    Nabbout, Rima
    Sanchez-Carpintero, Rocio
    Shiloh-Malawsky, Yael
    Wong, Matthew
    Zolnowska, Marta
    Checketts, Daniel
    Dunayevich, Eduardo
    Devinsky, Orrin
    [J]. EPILEPSIA, 2021, 62 (10) : 2505 - 2517
  • [8] Dravet syndrome: The long-term outcome
    Genton, Pierre
    Velizarova, Reana
    Dravet, Charlotte
    [J]. EPILEPSIA, 2011, 52 : 44 - 49
  • [9] Stiripentol efficacy and safety in Dravet syndrome: a 12-year observational study
    Myers, Kenneth A.
    Lightfoot, Paul
    Patil, Shekhar G.
    Cross, J. Helen
    Scheffer, Ingrid E.
    [J]. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2018, 60 (06): : 574 - +
  • [10] COST-UTILITY ANALYSIS OF ADD-ON STIRIPENTOL VS CANNABIDIOL AND VS FENFLURAMINE IN DRAVET SYNDROME IN THE USA
    Weston, G.
    Yi, Y.
    Alexander, D.
    Serraz, B.
    Schad, C.
    Fourcroy, M.
    Marre, C.
    [J]. VALUE IN HEALTH, 2024, 27 (06) : S107 - S107
12345